Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 21 studies. P1071: CCR5 Vicriviroc (SCH-417690) DAIDS Number 10634 Research Area N/A Study Status Concluded P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Concluded P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded P1039: A Randomized Trial of ZDV/3TC/ABC vs. ZDV/3TC/LPV/r DAIDS Number 10046 Research Area Other Study Status Concluded P1036A: Directly Observed Therapy in HIV-Infected Adolescents. DAIDS Number 10193 Research Area Other Study Status Concluded P1036B: Directly Observed Therapy in HIV-Infected Adolescents DAIDS Number 10044 Research Area Other Study Status Concluded P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV DAIDS Number 10316 Research Area Other Study Status Concluded Pagination Previous page Prev Page 1 Current page 2 Page 3 Next page Next
P1070: EFV in HIV-infected and HIV/TB Co-infected Subjects DAIDS Number 10633 Research Area Treatment Study Status Concluded
P1068S: Parasitemia And Clinical Malaria In Children On Protease-Inhibitor-Based Therapy DAIDS Number 10661 Research Area Other Study Status Concluded
P1066: Raltegravir Safety, Tolerability, PK, & Antiretroviral Activity DAIDS Number 10495 Research Area Treatment Study Status Concluded
P1065: Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth (Versions 1.0 - 3.0) and Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth (Version 4.0) DAIDS Number 10396 Research Area Other Study Status Concluded
P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations DAIDS Number 10809 Research Area Other Study Status Concluded
P1039: A Randomized Trial of ZDV/3TC/ABC vs. ZDV/3TC/LPV/r DAIDS Number 10046 Research Area Other Study Status Concluded
P1036A: Directly Observed Therapy in HIV-Infected Adolescents. DAIDS Number 10193 Research Area Other Study Status Concluded
P1036B: Directly Observed Therapy in HIV-Infected Adolescents DAIDS Number 10044 Research Area Other Study Status Concluded
P1011: Serostim Growth Hormone Dose-Finding Study in Children With HIV DAIDS Number 10316 Research Area Other Study Status Concluded